Clinical Trial Update: Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial investigating immunotherapy with Yttrium-90 radioembolization and SBRT for colorectal liver metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Immunotherapy (unspecified)
• Yttrium-90 (yttrium-90)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Colorectal Cancer | Phase 1 | Status: WITHDRAWN